about
Selective serotonin reuptake inhibitors (SSRIs) for stroke recoveryPharmaceutical interventions for emotionalism after strokeInterventions for preventing depression after strokeInterventions for preventing depression after strokeAmyotrophic lateral sclerosis and palliative care: where we are, and the road ahead.Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect.Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia?Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments.Treatment of depression in comorbid medical illness.Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives.Pharmacologic treatment of poststroke depression: a systematic review of the literature.Treatment of psychiatric syndromes due to cerebrovascular disease.Psychiatric and behavioral manifestations of vascular dementia.Current concepts in the pharmacotherapy of pseudobulbar affect.Managing depression in brain injury rehabilitation: the use of an integrated care pathway and preliminary report of response to sertraline.Short onset of action of a serotonin reuptake inhibitor when used to reduce premenstrual irritability.Management of post-stroke mood and emotional disturbances.Associations of serotonergic genes with poststroke emotional incontinence.Crossed aphasia: Two new cases
P2860
Q24202939-01B2BFD6-BF2D-4DCA-9A0D-461607B65BF7Q24240045-BEC98887-3806-4B54-BCB2-7E1C5C4A9E50Q24242197-57CE2230-5412-4A3C-A889-9478D3E5CE8DQ24247150-D2D256FE-5638-417D-8432-7F9BC44072BDQ30455100-F8BB8E75-26F6-4B52-B46B-0E98D58DE4D6Q30634431-B8484B51-B0C5-45A8-9034-8A9BC7BCB3D6Q33492926-DE106F0E-771A-4100-8864-8D4F2FE3A4A7Q34026748-BF7BB3A9-AE96-4E06-A670-4C6C39A4E063Q34181825-E0D49B74-4137-4BC6-B9EB-D07F254DA375Q34643816-8FCF7C70-BF10-4D84-BFD7-E86EDE0AA59FQ35217444-A760AD14-87C9-41FF-B08B-84BC06D40A99Q36645263-A51BF252-9C66-43AA-AF28-93C92DD87C27Q36812783-1666DD9D-9A24-4B58-8417-819C69F27631Q37895256-8438166F-4964-4A38-AC73-CE694C1C2E77Q42676479-54CF5068-C38D-4729-A908-5822B34524F9Q46505768-1DA8414E-9303-4F1B-BD18-8995EC47924EQ47731936-1BF9E33F-9E4E-4590-AD47-D1DF407B8A41Q48900895-443D56E0-61AA-4CD2-81B7-D206638EE34DQ58252063-768EBCEC-8707-42E6-86FF-23E161817A61
P2860
description
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
article
@en
im August 1999 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel (gepubliceerd in 1999-08)
@nl
наукова стаття, опублікована в серпні 1999
@uk
مقالة علمية (نشرت في أغسطس 1999)
@ar
ലേഖനം
@ml
name
Sertraline in stroke-associated lability of mood
@ast
Sertraline in stroke-associated lability of mood
@en
type
label
Sertraline in stroke-associated lability of mood
@ast
Sertraline in stroke-associated lability of mood
@en
prefLabel
Sertraline in stroke-associated lability of mood
@ast
Sertraline in stroke-associated lability of mood
@en
P2093
P2860
P1476
Sertraline in stroke-associated lability of mood
@en
P2093
Alistair Burns
Eve Russell
Hilary Stratton-Powell
Paul O'Neill
Pippa Tyrell
Robert Baldwin
P2860
P304
P356
10.1002/(SICI)1099-1166(199908)14:8<681::AID-GPS49>3.0.CO;2-Z
P407
P577
1999-08-01T00:00:00Z